We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$296M
2
SMCI icon
Super Micro Computer
SMCI
+$134M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$106M
4
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$76.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$58.2M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLQT icon
3426
SelectQuote
SLQT
$126M
$15K ﹤0.01%
4,039
-2,749
-40% -$7.01K
QURE icon
3427
uniQure
QURE
$3.26B
$15K ﹤0.01%
849
-1,220
-59% -$10.5K
GSLC icon
3428
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16.1B
$15K ﹤0.01%
+130
New +$15.1K
AGEN
3429
Agenus
AGEN
$315M
$15K ﹤0.01%
5,464
-4,148
-43% -$15.4K
DFTX
3430
Definium Therapeutics
DFTX
$5.9B
$15K ﹤0.01%
2,150
-1,895
-47% -$13K
BOC icon
3431
Boston Omaha
BOC
$436M
$15K ﹤0.01%
1,055
+171
+19% +$2.54K
VIOO icon
3432
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.35B
$15K ﹤0.01%
141
+137
+3,425% +$15.2K
AKBA icon
3433
Akebia Therapeutics
AKBA
$241M
$14.9K ﹤0.01%
7,865
-1,201
-13% -$2.08K
AMPL icon
3434
Amplitude
AMPL
$1.66B
$14.9K ﹤0.01%
1,416
-1,413
-50% -$14.1K
VEL icon
3435
Velocity Financial
VEL
$711M
$14.9K ﹤0.01%
763
-2,552
-77% -$50.7K
HSTM icon
3436
HealthStream
HSTM
$849M
$14.9K ﹤0.01%
469
-4,733
-91% -$146K
ATEN icon
3437
A10 Networks
ATEN
$2B
$14.9K ﹤0.01%
810
-2,563
-76% -$41.8K
INBX icon
3438
Inhibrx
INBX
$1.42B
$14.9K ﹤0.01%
967
+74
+8% +$1.13K
CIX icon
3439
Comp X International
CIX
$386M
$14.9K ﹤0.01%
569
+15
+3% +$436
BLMN icon
3440
Bloomin' Brands
BLMN
$924M
$14.9K ﹤0.01%
1,218
-3,308
-73% -$47.4K
PPTA
3441
Perpetua Resources
PPTA
$3.1B
$14.9K ﹤0.01%
1,392
+926
+199% +$9.5K
PARAA
3442
DELISTED
Paramount Global Class A
PARAA
$14.9K ﹤0.01%
666
+89
+15% +$1.99K
TCMD icon
3443
Tactile Systems Technology
TCMD
$537M
$14.8K ﹤0.01%
866
-4,781
-85% -$76.8K
MBX
3444
MBX Biosciences
MBX
$3.23B
$14.8K ﹤0.01%
803
+649
+421% +$13.8K
INVX
3445
Innovex International
INVX
$2.15B
$14.8K ﹤0.01%
1,058
-1,998
-65% -$30K
ESPR
3446
DELISTED
Esperion Therapeutics
ESPR
$14.8K ﹤0.01%
6,708
-3
-0% -$7
CZNC icon
3447
Citizens & Northern Corp
CZNC
$466M
$14.8K ﹤0.01%
793
+263
+50% +$5.15K
PWOD
3448
DELISTED
Penns Woods Bancorp
PWOD
$14.7K ﹤0.01%
+485
New +$13.9K
INGN icon
3449
Inogen
INGN
$154M
$14.7K ﹤0.01%
1,604
+535
+50% +$5K
CGTX icon
3450
Cognition Therapeutics
CGTX
$98.9M
$14.7K ﹤0.01%
20,970
+9,980
+91% +$4.93K
136 137
138
139 140

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.